Barbara C. Vanderhyden

11.7k citations

151 papers · 7.5k indexed · h-index 49

Reproductive Medicine top 0.1%
- Ovarian cancer diagnosis and treatment 30
- Sperm and Testicular Function 12
- Ovarian function and disorders 11
Public Health, Environmental and Occupational Health top 0.5%
- Reproductive Biology and Fertility 45
Cancer Research top 2%
Molecular Biology top 2%
Genetics top 1%
- Virus-based gene therapy research 12
Oncology
- Cancer Cells and Metastasis 11
Immunology
- Reproductive System and Pregnancy 11
- Immune Cell Function and Interaction 10

Co-authors: David P. Cook David T. Armstrong Roberto Buccione Tanya J. Shaw Gerald M. Kidder Fiona H. Thomas Paul Morley Kenneth Garson
Cited by: Reproductive Medicine Public Health, Environmental and Occupational Health Cancer Research
Journals: Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)Nature Communications (3 papers)
Partner nations: Canada United States China

In The Last Decade

Barbara C. Vanderhyden

147 papers receiving 7.3k citations

Peers

Countries citing papers authored by Barbara C. Vanderhyden

Since Specialization

Citations

This map shows the geographic impact of Barbara C. Vanderhyden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara C. Vanderhyden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara C. Vanderhyden more than expected).

Fields of papers citing papers by Barbara C. Vanderhyden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara C. Vanderhyden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara C. Vanderhyden. The network helps show where Barbara C. Vanderhyden may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Barbara C. Vanderhyden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barbara C. Vanderhyden Line = papers co-authored together Barbara C. Vanderhyden links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Specific Genetic Mutations Impact Chemotherapy Resistance and Therapeutic Efficacy of Oncolytic Viruses in Ovarian Cancer Molecular Cancer Therapeutics ·Alison O. Cudmore,Galaxia M. Rodriguez,Vincent Maranda,Salar Farokhi Boroujeni,Humaira Murshed,Elizabeth A. Macdonald,Mélanie Grondin,Kenneth Garson,Kathy Matuszewska,Jean‐Simon Diallo,Jim Petrik,Barbara C. Vanderhyden	2025	0
2	Loss of LATS1 and LATS2 promotes ovarian tumor formation by enhancing AKT activity and PD-L1 expression Oncogene ·Yalun Zhu,Atefeh Abedini,Galaxia M. Rodriguez,Curtis W. McCloskey,John Abou‐Hamad,Omar Salah Salah,Janie Larocque,Mayra Tsoi,Derek Boerboom,David P. Cook,Barbara C. Vanderhyden	2025	1
3	Transcriptional regulation of the postnatal cardiac conduction system heterogeneity Nature Communications ·Yena Oh,Rimshah Abid,Saif Dababneh,Marwan Bakr,Termeh Aslani,David P. Cook,Barbara C. Vanderhyden,Jin G. Park,Nikhil Munshi,Chi‐chung Hui,Kyoung-Han Kim	2024	3
4	FGL2 promotes tumour growth and attenuates infiltration of activated immune cells in melanoma and ovarian cancer models Scientific Reports ·Kristianne J.C. Galpin,Galaxia M. Rodriguez,Vincent Maranda,David P. Cook,Elizabeth A. Macdonald,Humaira Murshed,Zhao Shan,Curtis W. McCloskey,Andrzej Chruscinski,Gary Levy,Michele Ardolino,Barbara C. Vanderhyden	2024	7
5	Single-Cell RNA Sequencing Reveals Repair Features of Human Umbilical Cord Mesenchymal Stromal Cells American Journal of Respiratory and Critical Care Medicine ·Chanèle Cyr-Depauw,David P. Cook,Ivana Mižik,Flore Lesage,Arul Vadivel,Laurent Renesme,Yupu Deng,Shumei Zhong,Pauline Bardin,Liqun Xu,Marius A. Möbius,Jenny Marzahn,Daniel Freund,Duncan J. Stewart,Barbara C. Vanderhyden,Mario Rüdiger,Bernard Thébaud	2024	6
6	Single-Cell RNA Sequencing to Guide Autologous Preterm Cord Mesenchymal Stromal Cell Therapy American Journal of Respiratory and Critical Care Medicine ·Chanèle Cyr-Depauw,Ivana Mižik,David P. Cook,Flore Lesage,Arul Vadivel,Laurent Renesme,Yupu Deng,Shumei Zhong,Pauline Bardin,Liqun Xu,Marius A. Möbius,Jenny Marzahn,Daniel Freund,Duncan J. Stewart,Barbara C. Vanderhyden,Mario Rüdiger,Bernard Thébaud	2024	0
7	Sox10-Deficient Drug-Resistant Melanoma Cells Are Refractory to Oncolytic RNA Viruses Cells ·John Abou‐Hamad,Jonathan J. Hodgins,Edward Yakubovich,Barbara C. Vanderhyden,Michele Ardolino,Luc A. Sabourin	2023	2
8	Androgen-induced exosomal miR-379-5p release determines granulosa cell fate: cellular mechanism involved in polycystic ovaries Journal of Ovarian Research ·Reza Salehi,Brandon A. Wyse,Meshach Asare-Werehene,Fereshteh Esfandiarinezhad,Atefeh Abedini,Bo Pan,Yoko Urata,Alex Gutsol,Jose L. Viñas,Sahar Jahangiri,Kai Xue,Yunping Xue,Kevin D. Burns,Barbara C. Vanderhyden,Julang Li,Yutaka Osuga,Dylan Burger,Seang Lin Tan,Clifford Librach,Benjamin K. Tsang	2023	10
9	Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy Molecular Therapy ·Boaz Wong,Anabel Bergeron,Glib Maznyi,K. W. Ng,Anna Jirovec,Harsimrat Kaur Birdi,Daniel Serrano,Marcus M. Spinelli,Max Thomson,Zaid Taha,Akram Alwithenani,Andrew Chen,Ian A.J. Lorimer,Barbara C. Vanderhyden,Rozanne Arulanandam,Jean‐Simon Diallo	2023	11
10	Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer Communications Biology ·David P. Cook,Kristianne J.C. Galpin,Galaxia M. Rodriguez,Noor Shakfa,Juliette Wilson‐Sanchez,Maryam Echaibi,Madison Pereira,Kathy Matuszewska,Jacob Haagsma,Humaira Murshed,Alison O. Cudmore,Elizabeth A. Macdonald,Alicia Tone,Trevor G. Shepherd,Jim Petrik,Madhuri Koti,Barbara C. Vanderhyden	2023	11
11	The Tumor Immune Profile of Murine Ovarian Cancer Models: An Essential Tool for Ovarian Cancer Immunotherapy Research Cancer Research Communications ·Galaxia M. Rodriguez,Kristianne J.C. Galpin,David P. Cook,Edward Yakubovich,Vincent Maranda,Elizabeth A. Macdonald,Juliette Wilson‐Sanchez,Anjali L. Thomas,Joanna E. Burdette,Barbara C. Vanderhyden	2022	15
12	Single-Cell RNA Sequencing-Based Characterization of Resident Lung Mesenchymal Stromal Cells in Bronchopulmonary Dysplasia Stem Cells ·Ivana Mižíková,Flore Lesage,Chanèle Cyr-Depauw,David P. Cook,Maria Hurskainen,Satu Hänninen,Arul Vadivel,Pauline Bardin,Shumei Zhong,Olli Carpén,Barbara C. Vanderhyden,Bernard Thébaud	2021	14
13	The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergy Communications Biology ·Rozanne Arulanandam,Zaid Taha,Vanessa da Silva Garcia,Mohammed Selman,Andrew Chen,Oliver Varette,Anna Jirovec,Keara Sutherland,Elizabeth A. Macdonald,Fanny Tzelepis,Harsimrat Kaur Birdi,Nouf Alluqmani,Anne Landry,Anabel Bergeron,Barbara C. Vanderhyden,Jean‐Simon Diallo	2020	11
14	miR-590-3p Promotes Ovarian Cancer Growth and Metastasis via a Novel FOXA2–Versican Pathway Cancer Research ·Mohamed A. Salem,Jacob A. O’Brien,Stefanie Bernaudo,Heba Shawer,Gang Ye,Jelena Brkić,Asma Amleh,Barbara C. Vanderhyden,Basel Refky,Burton B. Yang,Sergey N. Krylov,Chun Peng	2018	78
15	17β-Estradiol sensitizes ovarian surface epithelium to transformation by suppressing Disabled-2 expression Scientific Reports ·Nhung Vuong,Omar Salah Salah,Barbara C. Vanderhyden	2017	8
16	Divergent Roles of PAX2 in the Etiology and Progression of Ovarian Cancer Cancer Prevention Research ·Ensaf M. Al-Hujaily,Yong Tang,Desheng Yao,Eurı́dice Carmona,Kenneth Garson,Barbara C. Vanderhyden	2015	21
17	17β-Estradiol Accelerates Tumor Onset and Decreases Survival in a Transgenic Mouse Model of Ovarian Cancer Endocrinology ·Laura A. Laviolette,Kenneth Garson,Elizabeth A. Macdonald,Mary K. Senterman,Kerri Courville,Colleen Crane,Barbara C. Vanderhyden	2010	49
18	Models of ovarian cancer—Are we there yet? Molecular and Cellular Endocrinology ·Kenneth Garson,Tanya J. Shaw,Katherine Clark,Desheng Yao,Barbara C. Vanderhyden	2005	53
19	Molecular basis of ovarian development and function Frontiers in bioscience ·Barbara C. Vanderhyden	2002	45
20	Oocytectomy Does Not Influence Synthesis of Hyaluronic Acid by Pig Cumulus Cells: Retention of Hyaluronic Acid After Insulin-Like Growth Factor-I Treatment in Serum-Free Medium1 Biology of Reproduction ·Eva Nagyová,Radek Procházka,Barbara C. Vanderhyden	1999	38

About Barbara C. Vanderhyden

Barbara C. Vanderhyden is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Immunology, having authored 151 papers that have together received 7.5k indexed citations. Recurring topics across this work include Reproductive Biology and Fertility (45 papers), Ovarian cancer diagnosis and treatment (30 papers), Virus-based gene therapy research (12 papers), Sperm and Testicular Function (12 papers), Ovarian function and disorders (11 papers), Cancer Cells and Metastasis (11 papers), Reproductive System and Pregnancy (11 papers) and Immune Cell Function and Interaction (10 papers). The work is most often cited by research in Reproductive Medicine (2.5k citations), Public Health, Environmental and Occupational Health (2.6k citations) and Cancer Research (851 citations). Barbara C. Vanderhyden has collaborated with scholars based in Canada, United States and China. Frequent co-authors include David P. Cook, David T. Armstrong, Roberto Buccione, Tanya J. Shaw, Gerald M. Kidder, Fiona H. Thomas, Paul Morley, Kenneth Garson, Mary K. Senterman and Elizabeth A. Macdonald. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact